Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 18, 2002New England Journal of MedicineOpen Access

Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SHSalima Hacein‐Bey‐AbinaCentre National de la Recherche ScientifiqueFCFrédérique CarlierHôpital Necker-Enfants MaladesCBCécile BouneaudInserm

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hacein‐Bey‐Abina et al. (2002) studied this question.

synapsesocial.com/papers/6a819e68b35cb7638cee22efhttps://doi.org/10.1056/nejmoa012616
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Detection and Direct Genomic Sequencing of Multiple Rare Unknown Flanking DNA in Highly Complex Samples2001 · 165 citations
  2. 2T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool1999 · 173 citations
  3. 3Intrinsic defects of B cell function in X-linked severe combined immunodeficiency2000 · 56 citations
  4. 4A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays1993 · 263 citations
  5. 5The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments.1993 · 643 citations